Enzo Biochem, Inc. (ENZ)

Enzo Biochem Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	55	74	115	158	114	186
Market Cap Growth	-57.60%	-36.26%	-26.93%	38.64%	-38.70%	-10.81%
Enterprise Value	5	-2	103	137	99	131
PE Ratio	1.16	3.63	-6.32	20.07	-4.00	74.71
PS Ratio	11.66	2.37	3.54	1.34	1.50	2.29
PB Ratio	0.80	0.94	2.12	2.30	1.95	2.16
P/FCF Ratio	-1.23	-1.85	-5.76	-39.03	-5.89	-56.01
P/OCF Ratio	-1.26	-1.99	-6.96	408.32	-6.63	38.69
EV/Sales Ratio	1.09	-0.06	3.15	1.17	1.30	1.61
EV/EBITDA Ratio	0.12	-0.07	-6.59	13.04	-3.78	29.27
EV/EBIT Ratio	0.12	-0.08	-5.58	17.44	-3.41	91.27
EV/FCF Ratio	-0.08	0.04	-5.13	-33.88	-5.11	-39.40
Debt / Equity Ratio	0.11	0.09	0.17	0.33	0.56	0.06
Debt / EBITDA Ratio	0.16	0.29	-0.58	2.16	-1.25	1.12
Debt / FCF Ratio	-0.17	-0.18	-0.45	-5.60	-1.70	-1.50
Quick Ratio	2.82	2.18	2.03	2.06	1.74	4.43
Current Ratio	3.50	2.46	3.29	2.71	2.10	5.09
Asset Turnover	0.05	0.35	0.33	1.04	0.65	0.81
Interest Coverage	-	19.08	-	-	-	-
Return on Equity (ROE)	61.20%	46.30%	-29.40%	12.40%	-42.30%	3.10%
Return on Assets (ROA)	42.50%	22.80%	-18.40%	7.00%	-24.20%	2.50%
Return on Capital (ROIC)	5.37%	-28.94%	-26.82%	0.76%	-33.30%	1.90%
Earnings Yield	81.24%	27.57%	-15.81%	4.98%	-25.02%	1.34%
FCF Yield	-78.46%	-53.99%	-17.37%	-2.56%	-16.98%	-1.79%
Buyback Yield / Dilution	-3.71%	-1.16%	-0.56%	-1.32%	-0.46%	-1.07%
Total Shareholder Return	-3.71%	-1.16%	-0.56%	-1.32%	-0.46%	-1.07%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).